Ekso Bionics Holdings Inc
NASDAQ:EKSO
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.82
10.58
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
Ekso Bionics Holdings Inc
NASDAQ:EKSO
|
27.9m USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
210.6B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
189.1B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
137.5B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
135.2B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
126.4B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
58B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
49.7B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
54.9B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.5B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
37B USD |
Loading...
|
Market Distribution
| Min | -4 087 900% |
| 30th Percentile | -5.1% |
| Median | 6% |
| 70th Percentile | 14.8% |
| Max | 1 032 600% |
Other Profitability Ratios
Ekso Bionics Holdings Inc
Glance View
Ekso Bionics Holdings, Inc. engages in the design, development and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company is headquartered in Richmond California, California and currently employs 45 full-time employees. The company went IPO on 2013-04-10. The Company’s exoskeleton technology serves multiple markets and can be utilized both by able-bodied users and persons with physical disabilities. The firm operates in two segments: EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform repetitive work. Its products include EksoNR and EksoUE. EksoNR is a rehabilitation device that assists physical therapists and physicians to treat patients who have suffered an acquired brain injury, stroke or spinal cord injury. EksoUE is a wearable upper body exoskeleton that assists patients with a broad range of upper extremity impairments.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Ekso Bionics Holdings Inc is -73.7%, which is above its 3-year median of -83.2%.
Over the last 3 years, Ekso Bionics Holdings Inc’s Operating Margin has increased from -116.5% to -73.7%. During this period, it reached a low of -120.5% on Dec 31, 2022 and a high of -58.4% on Dec 31, 2024.